Idexx Laboratories (IDXX) Other Non-Current Liabilities (2009 - 2026)

Idexx Laboratories (IDXX) has reported Other Non-Current Liabilities for 18 consecutive years, with $54.0 million the latest figure, recorded in Q1 2026.

• In Q1 2026, Other Non-Current Liabilities rose 13.21% year-over-year to $54.0 million; the TTM figure through Mar 2026 stood at $54.0 million (up 13.21% YoY), while the FY2025 annual figure was $56.5 million, up 27.48% from the prior year.
• Other Non-Current Liabilities came in at $54.0 million for Q1 2026 at Idexx Laboratories, down from $56.5 million in the prior quarter.
• The five-year high for Other Non-Current Liabilities was $71.8 million in Q1 2022, with the low at $44.3 million in Q4 2024.
• Average Other Non-Current Liabilities over 5 years is $61.2 million, with a median of $62.9 million recorded in 2024.
• Across the five-year window, Other Non-Current Liabilities tumbled 32.33% in 2024 and increased 27.48% in 2025, its largest moves.
• Year by year, Other Non-Current Liabilities stood at $67.6 million in 2022, then retreated by 3.05% to $65.5 million in 2023, then sank by 32.33% to $44.3 million in 2024, then climbed by 27.48% to $56.5 million in 2025, then fell by 4.41% to $54.0 million in 2026.
• According to Business Quant data, Other Non-Current Liabilities over the past three periods registered $54.0 million, $56.5 million, and $57.6 million for Q1 2026, Q4 2025, and Q3 2025 respectively.